The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.18
Bid: 16.16
Ask: 16.38
Change: -0.06 (-0.37%)
Spread: 0.22 (1.361%)
Open: 17.00
High: 17.00
Low: 16.18
Prev. Close: 16.24
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Term loan facility agreement

25 Aug 2023 14:09

RNS Number : 5115K
EnQuest PLC
25 August 2023
 

 

 

 

EnQuest PLC, 25 August 2023

 

Agreement of term loan facility

 

EnQuest PLC ('EnQuest' or the 'Group') is pleased to announce it has agreed a term loan facility (the 'loan') of up to $150 million, maturing in July 2027, which will rank junior to the Group's existing $500 million reserve based lending facility (the 'RBL') as a secured second lien instrument within the capital structure. As at 31 July 2023, only $240 million of the RBL facility was drawn against an original commitment of $500 million.

 

The loan proceeds will be used for general corporate purposes and are expected to provide an additional source of liquidity in advance of the October settlement of the 7% GBP retail bond. EnQuest expects to satisfy all conditions and complete the loan within 30 days from signing. EnQuest was advised by Rothschild & Co and Ashurst.

 

Within the loan, Double A Limited, a company beneficially owned by the extended family of Amjad Bseisu, has agreed to lend $9 million on the same terms and conditions as all other lending parties. This is considered a smaller related party transaction under Listing Rule 11.1.10. EnQuest has obtained written confirmation from a sponsor that, given the aforementioned terms and conditions, Double A's participation in the loan is fair and reasonable as far as EnQuest's shareholders are concerned.

 

Commenting on this agreement, EnQuest's Chief Financial officer, Salman Malik, said:

 

"We continue to de-lever our balance sheet and optimise our capital structure in response to the impact of the Energy Profits Levy on available borrowing capacity under the RBL. We are pleased to have secured this source of financing to extend our debt maturities and build optionality within the balance sheet as we look to support accretive growth opportunities. We thank our lending syndicate for their enhanced support."

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRPAMJTMTMTBFJ
Date   Source Headline
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company
24th Feb 20223:00 pmRNSHolding(s) in Company
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company
15th Feb 20223:00 pmRNSHolding(s) in Company
11th Feb 202210:00 amRNSDirector/PDMR Shareholding
3rd Feb 20227:00 amRNSOperations update
7th Jan 20229:32 amRNSDirector/PDMR Shareholding
22nd Dec 20218:36 amRNSDirectorate Change
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.